Back to Peptide Therapy
Peptide Therapy

Thymosin Alpha-1

Immune-modulating peptide used in chronic viral, autoimmune and post-viral protocols.

Subcutaneous, 2× weekly
Physician-supervised

Overview

Thymosin Alpha-1 is a natural thymic peptide with regulatory approval in some countries for hepatitis B and C. In longevity practice it is used for immune modulation, post-viral recovery, and adjunctive cancer support (with oncology).

Key benefits

  • T-cell modulation
  • Post-viral recovery support
  • Adjunctive support in chronic infection
  • Immune resilience

How it works

Subcutaneous 2× weekly for 8–12 weeks; longer for chronic conditions.

Mechanism

Enhances thymic T-cell maturation and modulates innate and adaptive immunity.

Who is this for

  • Long-COVID and post-viral recovery
  • Chronic infection support
  • Immunosenescent adults 50+

Considerations & safety

Coordinate with oncology in cancer patients. Not FDA approved in the US.

This page is educational and not medical advice. All VitaFlow protocols require evaluation by a licensed Florida physician.

Frequently asked

Any autoimmune concerns?+

Discuss carefully with physician — modulation may aggravate some conditions.

Cycle length?+

8–12 weeks minimum for immune effects.

Can I combine with NAD+?+

Yes.

Evidence?+

Strongest evidence in hepatitis; longevity uses are extrapolated.

Related in Peptide Therapy

Ready to feel your best?

Meet with a VitaFlow physician to design a protocol tailored to your goals, biomarkers, and lifestyle.